Evidence map›Paper›PMID 40160800›Full record

ArticleACS omega2025

WO

Lior Carmel, Shiran Aharon, Dan Meyerstein, Yael Albo, Lonia Friedlander, Dror Shamir, Ariela Burg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lior CarmelChemical Sciences Department, Ariel University, Ariel 40700, Israel.
Shiran AharonChemical Sciences Department, Ariel University, Ariel 40700, Israel.
Dan MeyersteinChemical Sciences Department, Ariel University, Ariel 40700, Israel.
Yael AlboChemical Engineering Department, Ariel University, Ariel 40700, Israel.ORCID https://orcid.org/0000-0002-9873-0161
Lonia FriedlanderIlse Katz Institute for Nano-scale Science and Technology, Ilse Katz Institute for Nano-Scale Science and Technology, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Dror ShamirNuclear Research Centre Negev, Beer-Sheva 84190, Israel.
Ariela BurgChemical Engineering Department, Sami Shamoon College of Engineering, Beer-Sheva 8410802, Israel.ORCID https://orcid.org/0000-0002-1888-4225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To minimize the use of the chemicals that have traditionally been needed to treat toxic organic compounds, a WO

Identifiers

PMID40160800
PMCPMC11947826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.